SPONSOR
Roswell Park Cancer Institute
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2
Conditions studied: Acute Lymphoblastic Leukemia, PediatricAdvanced Malignant Solid NeoplasmClinical Stage III Gastroesophageal Junction AdenocarcinomaClinical Stage IV Gastroesophageal Junction AdenocarcinomaClinical Stage IVA Gastroesophageal Junction AdenocarcinomaClinical Stage IVB Gastroesophageal Junction Adenocarcinoma ALocally Advanced Colorectal CarcinomaLocally Advanced Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal AdenocarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma
Roswell Park Cancer Institute is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Acute Lymphoblastic Leukemia, Pediatric, Advanced Malignant Solid Neoplasm, Clinical Stage III Gastroesophageal Junction Adenocarcinoma, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Roswell Park Cancer Institute
How many clinical trials has Roswell Park Cancer Institute sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Roswell Park Cancer Institute, of which 3 are actively recruiting participants. These trials cover conditions including Acute Lymphoblastic Leukemia, Pediatric, Advanced Malignant Solid Neoplasm, Clinical Stage III Gastroesophageal Junction Adenocarcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Roswell Park Cancer Institute research focus on?
Roswell Park Cancer Institute clinical trials span Acute Lymphoblastic Leukemia, Pediatric, Advanced Malignant Solid Neoplasm, Clinical Stage III Gastroesophageal Junction Adenocarcinoma, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma, Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Roswell Park Cancer Institute clinical trial?
To participate in a Roswell Park Cancer Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Roswell Park Cancer Institute trials with current recruitment status updated daily.
Clinical Trials by Roswell Park Cancer Institute
NCT06074666
Recruiting
Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
Acute Lymphoblastic Leukemia, Pediatric
NCT04511039 Phase 1
Recruiting
Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer
Advanced Malignant Solid Neoplasm
NCT07017829 Phase 2
Recruiting
GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer
Advanced Lung Non-Small Cell Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology